SCHEMBL16486295

SCHEMBL16486295

Fc1ccc(-c2cc3c([nH]2)CCNC3)cc1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PKN2 Q16513 1/20 0.68
▸ PARP1 P09874 1/20 0.41
▸ MAPKAPK2 P49137 1/20 0.41
▸ HTR2A P28223 3/20 0.41
▸ HTR2C P28335 3/20 0.41
▸ HTR2B P41595 3/20 0.41
▸ HTR1A P08908 1/20 0.41
▸ HTR1D P28221 1/20 0.41
▸ HTR1E P28566 1/20 0.41
▸ HTR7 P34969 1/20 0.41
▸ HTR6 P50406 1/20 0.41
▸ MELK Q14680 1/20 0.38
▸ CCNB2 O95067 1/20 0.37
▸ CDK1 P06493 1/20 0.37
▸ CCNB1 P14635 1/20 0.37
▸ GSK3A P49840 1/20 0.37
▸ GSK3B P49841 1/20 0.37
▸ CDK5 Q00535 1/20 0.37
▸ CDK5R1 Q15078 1/20 0.37
▸ CCNB3 Q8WWL7 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL16486113 0.82 PKN2 (0.69) PKN2PARP1MAPKAPK2HTR2CHTR7
SCHEMBL7899137 0.81 PKN2 (1.00) PKN2MAPKAPK2CDK1GSK3AGSK3B
SCHEMBL16492225 0.80 PKN2 (0.51) PKN2PARP1HTR2AHTR2CMELK
Hydrochloric Acid SCHEMBL16485943 0.79 PKN2 (0.50) PKN2PARP1HTR2AHTR2CMELK
SCHEMBL16492156 0.76 PKN2 (0.54) PKN2PARP1ASIC3VCP
Hydrochloric Acid SCHEMBL17783214 0.75 PKN2 (0.52) PKN2PARP1ASIC3VCP
SCHEMBL16492169 0.75 PKN2 (0.52) PKN2MAPKAPK2HTR7MELKCDK1
Hydrochloric Acid SCHEMBL16486120 0.74 PKN2 (0.51) PKN2MAPKAPK2HTR7MELKCDK1
SCHEMBL17790289 0.71 PKN2 (0.48) PKN2PARP1ASIC3VCP
SCHEMBL16492261 0.71 PKN2 (0.62) PKN2MAPKAPK2CDK1GSK3AGSK3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3033342-A1 ANNELATED PYRROLES AND THEIR USE AS CRAC INHIBITORS Grünenthal GmbH (DE) 2016-06-22 — — EP disclosed
US-20160151337-A1 ANNELATED PYRROLES AND THEIR USE AS CRAC INHIBITORS GRUENENTHAL GMBH (DE) 2016-06-02 — — US disclosed
US-20160151337-A1 ANNELATED PYRROLES AND THEIR USE AS CRAC INHIBITORS GRUENENTHAL GMBH (DE) 2016-06-02 — — US disclosed
US-20160151337-A1 ANNELATED PYRROLES AND THEIR USE AS CRAC INHIBITORS GRUENENTHAL GMBH (DE) 2016-06-02 — — US disclosed
WO-2015022073-A1 ANNELATED PYRROLES AND THEIR USE AS CRAC INHIBITORS Grünenthal GmbH (DE) 2015-02-19 — — WO disclosed
WO-2015022073-A1 ANNELATED PYRROLES AND THEIR USE AS CRAC INHIBITORS Grünenthal GmbH (DE) 2015-02-19 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160151337-A1 ANNELATED PYRROLES AND THEIR USE AS CRAC INHIBITORS AADAC, PRRC2C, PRRC2A PKN2 3918/4885PARP1 473/4885MAPKAPK2 2516/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback